Your browser doesn't support javascript.
loading
Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC).
Bassir Nia, Anahita; Orejarena, Maria J; Flynn, Leigh; Luddy, Christina; D'Souza, Deepak Cyril; Skosnik, Patrick D; Pittman, Brian; Ranganathan, Mohini.
Afiliação
  • Bassir Nia A; Schizophrenia Neuropharmacology Research Group, VA Connecticut Healthcare System, West Haven, CT, USA. Anahita.bassirnia@yale.edu.
  • Orejarena MJ; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Anahita.bassirnia@yale.edu.
  • Flynn L; The Clinical Neuroscience Research Unit (CNRU), Connecticut Mental Health Center (CMHC), Room 333B, 34 Park St, New Haven, CT, 06519, USA. Anahita.bassirnia@yale.edu.
  • Luddy C; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • D'Souza DC; Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Science Center, Houston, TX, USA.
  • Skosnik PD; Schizophrenia Neuropharmacology Research Group, VA Connecticut Healthcare System, West Haven, CT, USA.
  • Pittman B; Schizophrenia Neuropharmacology Research Group, VA Connecticut Healthcare System, West Haven, CT, USA.
  • Ranganathan M; Schizophrenia Neuropharmacology Research Group, VA Connecticut Healthcare System, West Haven, CT, USA.
Psychopharmacology (Berl) ; 239(5): 1621-1628, 2022 May.
Article em En | MEDLINE | ID: mdl-35438304
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos